ArticleInfection and immunity1999

Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni.

T Ben-Yedidia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.